Adrien Costantini

Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab

Adrien Costantini, Catherine Julié, Coraline Duménil et al. · OncoImmunology · 2018 · 172 citations · Full text

Immunology, Immunoediting, Pathology +19

Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer

Ali Chour, Julie Denis, Céline Mascaux et al. · Journal of Thoracic Oncology · 2023 · 69 citations · Full text

Medicine, Liver Physiology, Apoptosis +11

Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression

Etienne Giroux‐Leprieur, Zofia Hélias‐Rodzewicz, Paul Takam Kamga et al. · Journal for ImmunoTherapy of Cancer · 2020 · 33 citations · Full text

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer

Adrien Costantini, Jennifer Corny, Vincent Fallet et al. · ERJ Open Research · 2018 · 26 citations · Full text

Advanced Nsclc, Phase Iii Trials, Medicine +10

Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer

Camille Mehlman, Paul Takam Kamga, Adrien Costantini et al. · Cancers · 2021 · 23 citations · Full text